As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/7/24  Armata Pharmaceuticals, Inc.      10-Q        3/31/24   68:4.9M                                   Toppan Merrill Bridge/FA 
  5/7/24  Armata Pharmaceuticals, Inc.      8-K:2,9      5/7/24   12:327K                                   Toppan Merrill Bridge/FA 
 4/29/24  Armata Pharmaceuticals, Inc.      ARS        12/31/23    1:18M                                    Toppan Merrill/FA        
 4/29/24  Armata Pharmaceuticals, Inc.      DEF 14A     6/12/24    1:1.4M                                   Toppan Merrill/FA        
 3/22/24  Armata Pharmaceuticals, Inc.      8-K:5,9     3/22/24   10:186K                                   Toppan Merrill/FA        
 3/21/24  Armata Pharmaceuticals, Inc.      10-K       12/31/23   82:8.1M                                   Toppan Merrill Bridge/FA 
 3/21/24  Armata Pharmaceuticals, Inc.      8-K:2,9     3/21/24   12:368K                                   Toppan Merrill Bridge/FA 
 3/18/24  Patti Joseph M                    4          Director²   1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Kramer Robin                      4          Director²   1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Peterson Todd C.                  4          Director²   1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Rychlik Richard                   4          Officer²    1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Schlesinger Sarah J.              4          Director²   1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Haimovitz Jules                   4          Director²   1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Odysseas Kostas D                 4          Director²   1:7K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
 3/18/24  Birx Deborah                      4          Dir.,Off.²  1:6K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
  3/4/24‡ Innoviva, Inc.                    SC 13D/A               1:69K  Armata Pharmaceuticals, Inc.      Broadridge Fin’l So… Inc 
          Innoviva Strategic Opportunities LLC³
  3/4/24  Armata Pharmaceuticals, Inc.      8-K:1,2,9    3/4/24   14:772K                                   Toppan Merrill/FA        
 1/23/24  Armata Pharmaceuticals, Inc.      S-8         1/23/24    4:109K                                   Toppan Merrill/FA        
12/26/23  Schlesinger Sarah J.              4          Director²   1:5K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        
12/26/23  Peterson Todd C.                  4          Director²   1:5K   Armata Pharmaceuticals, Inc.      Toppan Merrill/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.